APEC1621 Pediatric MATCH Study (Tumor Genetics)

Purpose of this Study

If you choose to join this study, you will:<ul>
<li>Have tumor tissue from a biopsy sent to a lab for genetic testing</li>
<li>Get an assignment to a study if your tumor tissue has a genetic change that is targeted by one or more of the drugs being tested in this study</li></ul>

Who Can Participate?

Eligibility

Children and adults with recurrent solid tumors, lymphoma, and CNS tumors who:<ul>
<li>Are 1-21 years of age</li>
<li>Have no uncontrolled infection</li>
<li>Have had a prior solid organ transplant</li></ul>

What is Involved?

We are doing this study to see if different study drugs or drug combinations that target specific genetic changes found in some cancers will shrink the tumor and/or prolong the time to progression.

Study Details

Full Title

APEC1621 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Master Version Control Document

Principal Investigator

Jessica
Sun

Protocol Number

PRO00087722

NCT ID

NCT03213704

Phase

II

Enrollment Status

Open to Enrollment